Detalhe da pesquisa
1.
Pyridostigmine reduces mortality of patients with severe SARS-CoV-2 infection: A phase 2/3 randomized controlled trial.
Mol Med
; 28(1): 131, 2022 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36348276
2.
A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol.
BMC Infect Dis
; 20(1): 765, 2020 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33066761
3.
Polymyositis: A Case Report.
Cureus
; 15(8): e43337, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37700938